Fiche détaillée de la technologie

Titre de la technologie / Technology Title
    S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
Description / Description
    The present invention relates to a method and composition for inducing leukocyte proliferation and migration, and for reducing the risks of microbial infections in patients immuno-suppressed. The present invention particularly relates to ,MRP which induces the proliferation, differentiation and release of immune cells from bone marrow. More particularly, S100A8, S100A9, S100A12 and S100A8/A9 are administered to patients with lowered neutrophil blood concentrations.
Inventeur / Inventor Collaborateur(s) / Collaborator(s)
  • Karen Vandal
  • Pascal Rouleau
  • Carle Ryckman
Contact / Contact Champs(s) d'intérêt(s) / Industry segment(s) Brevet(s) / Patent(s)
  • Canada
  • États-Unis
Numéro de la technologie / File Number : 00402